Sohanya Roshan Cheng, EVP & Chief Commercial Officer at Karyopharm Therapeutics Inc. (KPTI), sold 3,445 shares at $6.29 ($22K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Seasonal sale ($22k) by EVP & Chief Commercial Officer — this insider has traded KPTI in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2025-09-16 | $2K | — | Filing → |
| KPTI | SELL | 2024-09-05 | $4K | — | Filing → |
| KPTI | SELL | 2024-03-04 | $32K | — | Filing → |